# Revolution Medicines, Inc. (RVMD)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RVMD/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -1.16B | $ -798.33M | $ 158.70M | $ 1.63B |
| 2024 | $ 0 | $ -630.75M | $ -1.17B | $ 135.84M | $ 2.27B |
| 2023 | $ 12.52M | $ -471.82M | $ -749.49M | $ 87.94M | $ 1.83B |
| 2022 | $ 39.52M | $ -277.83M | $ -277.62M | $ 64.21M | $ 685.19M |
| 2021 | $ 34.93M | $ -222.39M | $ -343.87M | $ 66.63M | $ 602.57M |
| 2020 | $ 54.76M | $ -137.79M | $ -425.87M | $ 32.66M | $ 474.68M |
| 2019 | $ 64.59M | $ -61.52M | $ -195.66M | $ 0 | $ 152.54M |
| 2018 | $ 13.67M | $ -14.98M | $ -15.63M | $ 147.0K | $ 96.66M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.10 |
| Liabilities / Eq | 0.44 |
| Current Ratio | 7.14 |

## Other views

- [Metrics](https://sponda.capital/en/RVMD.md)
- [Charts](https://sponda.capital/en/RVMD/charts.md)
- [Compare](https://sponda.capital/en/RVMD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.